Skip to search formSkip to main contentSkip to account menu

Zirconium Zr 89 Cetuximab

Known as: Cetuximab-Zirconium-89, Cetuximab-Zr-89, Zirconium-89-Labeled Cetuximab 
A radioimmunoconjugate comprised of the recombinant chimeric monoclonal antibody cetuximab labeled with the radioisotope zirconium Zr 89 (Zr 89) with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Zirconium-89 tetraazamacrocycle complexes: the influence of macrocycle structure on stability
2017
2017
Abstract OT2-02-03: Pilot study of zirconium-89 bevacizumab positron emission tomography for imaging angiogenesis in patients with inflammatory breast carcinoma receiving preoperative chemotherapy
Background: Inflammatory breast cancer (IBC) continues to have a poor prognosis despite standard tri-modality treatment with… 
2014
2014
Abstract 2069: Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Introduction: STEAP1 (Six Transmembrane Epithelial Antigen… 
2012
2012
Imaging the LAT-1 amino acid transporter with Zr-89 immunoPET
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)